Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
---|---|---|---|
6/30/2025 | $ 29.88M | $ 674.71M | 22.58 |
3/31/2025 | $ -66.78M | $ 454.83M | 0 |
12/31/2024 | $ -82.79M | $ 455.11M | 0 |
9/30/2024 | $ -79.01M | $ 468.12M | 0 |
6/30/2024 | $ -61.6M | $ 388.01M | 0 |
3/31/2024 | $ -48.82M | $ 211.96M | 0 |
12/31/2023 | $ -44.55M | $ 224.8M | 0 |
9/30/2023 | $ -39.19M | $ 160.91M | 0 |
6/30/2023 | $ -32.29M | $ 130.83M | 0 |
3/31/2023 | $ -52.05M | $ 121.66M | 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / EBIT
(=) EV/EBIT
EV/EBIT for ZEVRA THERAPEUTICS INC is calculated as follows: EV [ $ 104.59M ] / EBIT [ $ -8.95M ]
(=) EV/EBIT [ 0 ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0.05 |
max | 62.03 |
average | 19.91 |
median | 16.78 |
std | 12.32 |